Multicentre cohort study evaluating clinical, oncological and functional outcomes following robotic rectal cancer surgery-the EUREKA collaborative: trial protocol

Collaborators, Affiliations

¹ Department of Colorectal Surgery, Bordeaux Colorectal Institute, Clinique Tivoli, Bordeaux, France.
² Department of Colorectal Surgery, Portsmouth Hospitals University NHS Trust and the University of Portsmouth, Portsmouth, UK.
³ Department of Surgery, University Medical Centre Groningen, Groningen, The Netherlands.
⁴ Clinical Research Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.
⁵ Department of Digestive and Oncological Surgery, Lyon University Hospital, Lyon-Sud Hospital, Pierre-Bénite, France.
⁶ Department of Colorectal Surgery, Chu Estaing, Clermont-Ferrand, France.
⁷ Department of Digestive Surgery, Colorectal Unit, Haut-Lévêque Hospital, Bordeaux University Hospital, Pessac, France.
⁸ Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands.
⁹ Surgery Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.

Christina A Fleming et al. BJS Open. 2024.

. 2024 Mar 1;8(2):zrae019.

doi: 10.1093/bjsopen/zrae019.

¹ Department of Colorectal Surgery, Bordeaux Colorectal Institute, Clinique Tivoli, Bordeaux, France.
² Department of Colorectal Surgery, Portsmouth Hospitals University NHS Trust and the University of Portsmouth, Portsmouth, UK.
³ Department of Surgery, University Medical Centre Groningen, Groningen, The Netherlands.
⁴ Clinical Research Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.
⁵ Department of Digestive and Oncological Surgery, Lyon University Hospital, Lyon-Sud Hospital, Pierre-Bénite, France.
⁶ Department of Colorectal Surgery, Chu Estaing, Clermont-Ferrand, France.
⁷ Department of Digestive Surgery, Colorectal Unit, Haut-Lévêque Hospital, Bordeaux University Hospital, Pessac, France.
⁸ Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands.
⁹ Surgery Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.

No abstract available

Figures

1. van der Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC et al. COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 2013;14:210–218 - PubMed
1. Park JW, Kang S-B, Hao J, Lim S-B, Choi HS, Kim D-W et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial. Lancet Gastroenterol Hepatol 2021;6:569–577 - PubMed
1. Stevenson ARL, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ et al. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 2015;314:1356–1363 - PubMed
1. Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J et al. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA 2017;318:1569–1580 - PMC - PubMed
1. Kim MJ, Park SC, Park JW, Chang HJ, Kim DY, Nam B-H et al. Robot-assisted versus laparoscopic surgery for rectal cancer: a phase II open label prospective randomized controlled trial. Ann Surg 2018;267:243–251 - PubMed